EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study

Robin W van Steenhoven iD, Saan Salih, Juna M de Vries, Ide Smets, Rob M Verdijk, Mayke Gardeniers, Jeroen Kerstens, Juliette Brenner iD, Yvette S Crijnen, Marjolein Geurts, Jacoline E C Bromberg, Corine H GeurtsvanKessel und 3 weitere

Annals of Clinical and Translational Neurology · 2025

DOI: 10.1002/acn3.70000 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Robin W van Steenhoven und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Central Nervous System Diseases, Brain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A substantial part of central nervous system (CNS) disorders remains unexplained, despite various new and minimally invasive diagnostic techniques. Within this rapidly developing diagnostic field, the precise role of brain biopsy is unknown. We aimed to study the clinical impact and safety of brain biopsies in unexplained CNS disorders.

Methods

In this retrospective cohort study, we included all adult patients who were referred for a diagnostic work‐up to our academic center with neuro‐inflammatory, neuro‐oncological, and neuro‐infectious expertise and underwent a brain biopsy between January 2010 and December 2023. Typical cases of CNS neoplasms and infections were not analyzed. Brain biopsies were evaluated with respect to diagnostic and therapeutic impact and complication risk.

Results

Brain biopsy was performed in 587 patients. Ninety‐four patients with a CNS disorder of unknown cause, with 107 biopsies, were analyzed (44% female, median age 58 years). Postoperative diagnoses included brain tumors/lymphomas (37/94, 39%), inflammatory disorders (11/94, 12%), infections (8/94, 9%), autoimmune encephalitis (8/94, 9%), and primary angiitis of the CNS (4/94, 4%). Diagnostic yield of brain biopsy was 62%, increasing up to 72% after repeat biopsies, as 10 additional patients were diagnosed with a brain tumor. In 77% of patients, brain biopsy changed the treatment strategy. Symptomatic intracranial hemorrhage occurred in 4 of 107 brain biopsies (4%).

Interpretation

In a selected population of patients with unexplained CNS disorders, clinical impact of brain biopsies is high, while being relatively safe. A multidisciplinary team approach is fundamental in establishing optimal indication for brain biopsy and subsequent treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System DiseasesBrainHumansFemaleMaleMiddle AgedRetrospective StudiesBiopsyAdultAgedBrain NeoplasmsCohort StudiesVasculitis, Central Nervous System

Autor:innen und Institutionen

  • Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Neurosurgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Neuropathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Robin W van Steenhoven, Juliette Brenner

Förderung

  • ZonMw

Zitieren

APA

van Steenhoven, R. W., Salih, S., de Vries, J. M., Smets, I., Verdijk, R. M., Gardeniers, M., Kerstens, J., Brenner, J., Crijnen, Y. S., Geurts, M., Bromberg, J. E. C., GeurtsvanKessel, C. H., Sillevis Smitt, P. A. E., Balvers, R. K., & Titulaer, M. J. (2025). Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70000

Vancouver

van Steenhoven RW, Salih S, de Vries JM, Smets I, Verdijk RM, Gardeniers M, et al. Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70000

BibTeX
@article{vanSteenhoven2025,
  author = {van Steenhoven, Robin W and Salih, Saan and de Vries, Juna M and Smets, Ide and Verdijk, Rob M and Gardeniers, Mayke and Kerstens, Jeroen and Brenner, Juliette and Crijnen, Yvette S and Geurts, Marjolein and Bromberg, Jacoline E C and GeurtsvanKessel, Corine H and Sillevis Smitt, Peter A E and Balvers, Rutger K and Titulaer, Maarten J},
  title = {Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  doi = {10.1002/acn3.70000}
}
Kostenlos starten →